AARP Travel’s (http://travel.aarp.org) newest research on Celebration Vacations is brought to life by AARP Travel Ambassador Samantha Brown in a new video available for download. Brown explains why Celebration Vacations are a popular way for America’s 76 million baby boomers to commemorate special milestones in life – such as anniversaries, birthdays, family reunions and weddings.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/66070-aarp-new-travel-website/
Walt Disney Records is set to release a new hologram vinyl version of the original motion picture soundtrack for Star Wars: The Force Awakens. With score conducted and composed by five-time Academy Award®-winning composer John Williams and liner notes by the film’s director, J.J. Abrams, the double LP features a 16-page booklet on 180 gram vinyl. This one-of-a-kind vinyl set, hand etched by Tristan Duke (Jack White’s Lazaretto) of Infinity Light Science, offers a 3D hologram experience featuring the Millennium Falcon on Disc 1/Side B and a TIE Fighter on Disc 2/Side B. For optimal viewing, use a direct light source or simply hold a mobile phone flashlight above the vinyl to view the holograms.
Tristan Duke founded Infinity Light Science in 2008, a research laboratory with an emphasis on laser holography, interferometry, light-field imaging, hand-drawn holography, and relativistic imaging.
The must-have vinyl album also features Direct Metal Mastering (DMM) for an optimal listening experience. Disney Music Group has joined forces with Pro-Ject Audio Systems to showcase this unique, next-level advancement in holographic vinyl technology with the Elemental turntable, a combination of minimalist design and maximum performance from the world leader in high fidelity turntables. The two brands will collaborate on co-promotions at retail, online, and radio.
To view the multimedia release go to:
http://www.multivu.com/players/English/7847351-star-wars-the-force-awakens-vinyl/
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, “Innovation in Medical Cannabis Therapies” (IMCT) Symposium, held on Friday, November 9th at the “Keep Memory Alive” Event Center at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. Throughout the day’s program, there was an emerging sense of heightened responsibility on the part of the cannabis industry to better address medical cannabis patients' needs through research and development of medical cannabis products that are better standardized, more easily-dosed, and made more widely-available to cannabis patients at a fair price.
To view the multimedia release go to:
https://www.multivu.com/players/English/8308958-gb-sciences-2018-medical-cannabis-therapies-symposium/
The Dubai Roads and Transport Authority (RTA) has announced the addition of a new category and an increase in the purse value of the Hamdan bin Mohammed Award for Innovation in Project Management. The increase, commences from the second edition of the award, following the huge success and overwhelming global participation for the inaugural edition of the award.
HE Mattar Al Tayer, Director General and Chairman of the Board of Executive Directors of the Roads and Transport Authority (RTA) cum Chairman of the Board of Trustees of the HBM Award for Innovation in Project Management said, “The Award prizemoney would be increased by 29% equivalent to AED2.6 MILLION (US$710,000). An Academic category has been added comprising two awards: Research in Innovative Project Management Practices Award and Innovative Use of Project Management Practices (Award Category) to engage students, academics and researchers. Winners of the Award would be honoured during the 5th Dubai International Project Management Forum (DIPMF) scheduled in December 2018.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8269451-registration-hbm-award-project-management/
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
Ahead of World Mental Health Day, today sees the publication of the Mental Health Integration Index, a new research initiative commissioned by the Janssen Pharmaceutical Companies of Johnson & Johnson and undertaken by the Economist Intelligence Unit.1 The research explores the challenges of integrating Europeans with mental illness into society and employment, within the European Union’s 28 Member States, plus Norway and Switzerland. Countries have been ranked according to their degree of commitment to support those living with mental illness; the findings demonstrate that while there are many examples of good practice across Europe, the whole region has a long way to go before people with mental illness are adequately supported and truly integrated into their communities.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762557-janssen-europe-mental-health-index/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Michelin today marked the opening of its newest plant in North America, which will produce the innovative MICHELIN® X® TWEEL® Airless Radial Tire™ for commercial applications.
An idea first conceived by Michelin research engineers in the United States, the TWEEL is a revolutionary non-pneumatic tire that changed the configuration of a conventional tire, bringing together the tire and the wheel assembly into one solid unit. The TWEEL comprises a rigid hub connected to a shear beam by means of flexible, deformable polyurethane spokes, all functioning as a single unit.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7381451-michelin-open-s-first-manufacturing-plant-tweel-airless-radial-tire/
At a time when educators and policymakers are placing a high priority on quality early childhood education, Wolf Trap Foundation for the Performing Arts today announced results of a four-year study showing that its arts integration teaching model bolsters young children’s math achievement. Additional resources, including a summary video with classroom demonstrations and the complete research report, may be accessed at http://www.wolftrap.org/stemartsstudy.
Conducted by independent evaluators at the American Institutes for Research (AIR), Findings from the Evaluation of the Wolf Trap Arts in Education Model (the Study) examined the effects of an arts-integrated teaching approach on teachers’ practice and students’ math knowledge.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7224251-wolf-trap-math-achievement/
Extremely painful and destructive, gout is the most common form of inflammatory arthritis with elevated serum uric acid (sUA) a root cause of the disease. Even with the growing incidence of gout, recent research from the Gout & Uric Acid Education Society (GUAES) found that just 16 percent of Americans overall know the target sUA number for gout (6 mg/dL or below) – and just 38 percent of people with gout had their sUA levels checked within the past six months, the timeframe recommended by the American College of Rheumatology. Additionally, the majority of gout sufferers don’t understand the importance of taking daily uric acid-lowering medications, with four in 10 incorrectly believing that they can stop taking medications when they aren’t experiencing flares.
Seeking to increase recognition of the severity of gout and need for routine sUA testing and management, GUAES hosted a professional roundtable discussion on October 3, 2015. The roundtable brought together several experts – rheumatologists, a family care physician, and representatives from the American Association of Diabetes Educators, the National Kidney Foundation and CreakyJoints – to explore how to more effectively educate about gout and improve access to public education and treatment.
To view the multimedia release go to:
http://www.multivu.com/players/English/7715851-guaes-gout-roundtable-discussion/
SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
In addition to educating consumers, SC Johnson is actively working with organizations around the world to donate and distribute product to those in need. In coordination with the U.S. Centers for Disease Control and Prevention (CDC) Foundation, SC Johnson supported the Zika Action Plan Summit held by the White House and the CDC on April 1, and also donated to the CDC's Zika Prevention Kits. Additional donations have been made to AmeriCares, the Rio de Janeiro-based Children’s Health Association and the County of Hawaii Civil Defense Agency.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology.
The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks.
To view the multimedia release go to:
https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
